Sowell Financial Services LLC Alnylam Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$128.63 - $176.89 $42,833 - $58,904	-333 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$126.83 - $175.69 $14,965 - $20,731	118 Added 54.88%	333 $44,000
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $11,463 - $17,208	-110 Reduced 33.85%	215 $32,000
Q1 2020 May 12, 2020	SELL	$93.12 - $133.99 $18,437 - $26,530	-198 Reduced 37.86%	325 $35,000
Q4 2019 Feb 07, 2020	BUY	$74.51 - $124.23 $37,105 - $61,866	498 Added 1992.0%	523 $60,000
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $1,772 - $2,195	25 New	25 $2,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.